Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 934 of 1,261
  1. US 8114446

    Methods for modulating eicosanoid metabolism

    The Board of Regents of the University of Texas System · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  2. US 8114830

    Polypeptoid pulmonary surfactants

    Northwestern University · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  3. US 8114834

    Self-assembling peptide amphiphiles

    Northwestern University · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  4. US 8114848

    Immunomodulatory oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  5. US 8114406

    Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  6. US 8114835

    Self-assembling peptide amphiphiles for tissue engineering

    Northwestern University · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  7. US 8114851

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  8. US 8114843

    Photoreactive regulator of protein function and methods of use thereof

    The Regents of the University of California · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  9. US 8114900

    Amorphous carvedilol dihydrogen phosphate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  10. US 8114981

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  11. US 8114852

    N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  12. US 8114984

    RNAi modulation of Aha and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  13. DE 102010033527

    Quetiapin-Tabletten

    ACINO PHARMA AG [CH] · Granted Feb 9, 2012 · Expires Feb 4, 2032

    granted
  14. US 8110209

    Intracutaneous injection

    XERIS PHARMACEUTICALS, INC. · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  15. US 8110546

    VEGF antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  16. US 8110554

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  17. US 8110569

    Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use

    The Regents of the University of California · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  18. US 8110192

    Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  19. US 8110354

    Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo

    The United States of America as represented by the Secretary of the Army · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  20. US 8109894

    Indwelling heat exchange catheter and method of using same

    The Regents of the University of California · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  21. US 8110379

    Targeted integration into the PPP1R12C locus

    Sangamo Biosciences, Inc. · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  22. US 8110352

    Method of diagnosing and treating cancer using B-catenin splice variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  23. US 8110585

    Bicyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted
  24. US 8110674

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.